{"metadata": {"source": "pubchem", "title": "Morphine | C17H19NO3 | CID 5288826 - PubChem", "description": "Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5288826", "drug": "Morphine", "cid": 5288826, "char_count": 201355, "word_count": 27013, "doc_id": "doc_53", "num_chunks": 298, "chunk_id": "53::chunk_56", "document_index": 53, "latency_s": 1.2842539999983273, "prompt_toks": 53644, "completion_toks": 65, "relevance_score": 0.16749083}, "content": "Drug: Morphine | cid: 5288826\nSource: pubchem | Source description: Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    experts, stakeholders, the public, peer reviewers, and a federally chartered advisory committee. It is important that patients receive appropriate pain treatment with careful consideration of the benefits and risks of treatment options. This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death.\n\n\n                    Context: \n                    This excerpt discusses guidelines designed to enhance communication between clinicians and patients regarding opioid therapy for chronic pain, aiming to improve safety, efficacy, and reduce risks such as addiction and overdose. It is relevant within the webpage's comprehensive overview of morphine, a key opioid, highlighting regulatory and clinical considerations important for medical and safety information retrieval.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Morphine (Avinza) Vault", "description": "Information about Morphine including uses, images, dosage, effects, legal status, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/pharms/morphine/morphine.shtml", "drug": "Morphine", "cid": 5288826, "substance": "morphine", "category": "PHARMS", "erowid_column": "MainPage", "char_count": 5144, "word_count": 726, "doc_id": "doc_199", "num_chunks": 7, "chunk_id": "199::chunk_5", "document_index": 199, "latency_s": 0.6474454999988666, "prompt_toks": 1845, "completion_toks": 64, "relevance_score": 0.0065388246}, "content": "Drug: Morphine | cid: 5288826\nSource: erowid | Source description: Information about Morphine including uses, images, dosage, effects, legal status, and links to other resources.\nErowid name: morphine\nCategory: PHARMS\nField: MainPage\n\n                    Text: \n                    Hotel Bathroom Extravaganza, by Atonable Junky\n\nTo Hell and Back, by Morphina\n\nBasic Morphine Prep and the Experience, by Drug Geek\n\nOn the Magickal Uses of Opioids, by Glozey\n\n» » » MORE » » »\n\nOFF-SITE RESOURCES\n\nPRIMARY RESOURCES #\n\nRxList : Morphine\n\nUN ODC : Morphine\n\nSECONDARY RESOURCES #\n\nMorphine - Wikipedia.org\n\nMorphine - TripSit.me\n\nMEDIA COVERAGE #\n\nEnding the agony: Access to morphine as an ethical and human rights imperative - IDPC, Apr 2018\n\n'War on drugs means millions are needlessly dying in pain' - CNN, Nov 2015\n\nStudy: Fast Morphine Treatment May Prevent PTSD - NYTimes, Jan 2010\n\nMorphine found to help stave off PTSD in wounded troops - Washington Post, Jan 2010\n\nMorphine Apparently in Your Head - Wired, Sep 2004\n\nHEALTH INFORMATION #\n\nAvinza Time Release Label with new Alcohol Warnings - Nov 2005, FDA\n\nGOVERNMENT ARTICLES #\n\nAcess to Controlled Medicines around the World in 2011 - WHO\n\n[ back to pharms ]\n\nCreated by Erowid - Feb 21, 2003 Modified - Jul 29, 2023\n\n\n                    Context: \n                    This section lists user experiences, media coverage, health information, and government resources related to morphine, providing additional context and external links within the Erowid pharmacology database. It enhances understanding of morphine's effects, legal status, and societal impact, making it valuable for research, harm reduction, and educational purposes.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Morphine (Avinza) Vault", "description": "Information about Morphine including uses, images, dosage, effects, legal status, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/pharms/morphine/morphine.shtml", "drug": "Morphine", "cid": 5288826, "substance": "morphine", "category": "PHARMS", "erowid_column": "MainPage", "char_count": 5144, "word_count": 726, "doc_id": "doc_199", "num_chunks": 7, "chunk_id": "199::chunk_6", "document_index": 199, "latency_s": 1.145110699988436, "prompt_toks": 1644, "completion_toks": 72, "relevance_score": 0.0020269002}, "content": "Drug: Morphine | cid: 5288826\nSource: erowid | Source description: Information about Morphine including uses, images, dosage, effects, legal status, and links to other resources.\nErowid name: morphine\nCategory: PHARMS\nField: MainPage\n\n                    Text: \n                    GOVERNMENT ARTICLES #\n\nAcess to Controlled Medicines around the World in 2011 - WHO\n\n[ back to pharms ]\n\nCreated by Erowid - Feb 21, 2003 Modified - Jul 29, 2023\n\nContent & design © 1995-2023 Erowid.org. Permission required before publicly reproducing Erowid info.\n\n\n                    Context: \n                    This chunk is part of the \"GOVERNMENT ARTICLES\" section within the pharmacy and drug information pages, specifically referencing a 2011 WHO report on global access to controlled medicines. It provides a link back to the main pharmaceuticals section and includes details about the content's creation and modification dates, emphasizing the publication's credibility and relevance to drug policy discussions.\n                "}
